Patent: 8,293,897
✉ Email this page to a colleague
Summary for Patent: 8,293,897
Title: | Compounds comprising a spiro-ring and methods of use |
Abstract: | The present invention provides novel compounds useful in modulating the protein tyrosine kinase activity, and in modulating inter--and/or intra--cellular signaling. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans. |
Inventor(s): | Xi; Ning (Thousand Oaks, CA) |
Assignee: | Xi; Ning (Newbury Park, CA) Sunshine Lake Pharma Co., Ltd. (Northern Industrial Area, Songshan Lake, Dongguan, Guangdong, CN) |
Application Number: | 12/576,375 |
Patent Claims: | see list of patent claims |
Details for Patent 8,293,897
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2028-10-14 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2028-10-14 |
Glaxosmithkline Llc | BEXXAR | tositumomab and iodine i-131 tositumomab | Injection | 125011 | 06/27/2003 | ⤷ Try a Trial | 2028-10-14 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |